Seeing Is Believing
Healthcare - Sector
with an average price target of $19.28. This is a potential upside of $12.13 (169.65%) from yesterday's end of day stock price of $7.15.
G1 Therapeutics's activity chart (see below) currently has 65 price targets and 57 ratings on display.
Analysts average stock forecasts to be materialized ratio is 25.87% with an average time for these price targets to be met of 97.67 days.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 06-Aug-2024. First documented stock forecast 11-Jun-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6
1 years 2 months 22 days ago
(06-Aug-2024)
1/9 (11.11%)
$3.8 (172.73%)
43
Buy
$3
$-4.15 (-58.04%)
$9
1 years 4 months 4 days ago
(24-Jun-2024)
1/11 (9.09%)
$0.8 (36.36%)
17
Buy
$4
$-3.15 (-44.06%)
$5
1 years 8 months 16 days ago
(12-Feb-2024)
4/8 (50%)
$1.9 (90.48%)
189
Sell
$10
2 years 23 days ago
(05-Oct-2023)
1/5 (20%)
$2.57 (34.59%)
86
Buy
$24
$16.85 (235.66%)
3 years 6 months 3 days ago
(25-Apr-2022)
1/4 (25%)
$18.07 (304.72%)
63
What is GTHX (G1 Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on GTHX (G1 Therapeutics) with a proven track record?
Which analyst has the current lower performing score on GTHX (G1 Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GTHX (G1 Therapeutics)?
Which analyst is the currently most bullish on GTHX (G1 Therapeutics)?
Which analyst is the currently most reserved on GTHX (G1 Therapeutics)?